Chronic Gastritis: Clinical Trials

10 trials for Chronic Gastritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 not yet recruiting, 1 unknown. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 8, Not yet recruiting 1, Unknown 1

Follow Chronic Gastritis: new trials by email Literature Review of Chronic Gastritis trials Research Report on Chronic Gastritis

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis
Stillen Tab., Sto M Tab. - Gastritis, Acute Gastritis
Phase 4Not yet recruitingMather's Pharm. Co., Ltd.4702026-06-012026-06-05
Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication
Berberine, Vonoprazan, Amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis
Phase 4CompletedXijing Hospital of Digestive Diseases5582024-09-202025-07-03
Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis
Triple Therapy, Quadruple Therapy - Helicobacter Pylori Infection, Chronic Gastritis
Phase 4CompletedAzfar Farogh7522024-01-052025-12-31
Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.
esomeprazole, Bismuth, Amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis
Phase 4UnknownXijing Hospital of Digestive Diseases5482023-11-202024-09-19
Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication
Berberine, Vonoprazan, Amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis
Phase 4CompletedXijing Hospital of Digestive Diseases3002021-12-012023-01-31
Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy
Berberine, Amoxicillin, Rabeprazole - Dyspepsia, Chronic Gastritis
Phase 4CompletedXijing Hospital of Digestive Diseases5242021-01-072023-01-31
Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
Berberine, Amoxicillin, Esomeprazole - Gastric Ulcer, Chronic Gastritis
Phase 4CompletedXijing Hospital of Digestive Diseases6582018-08-012019-08-30
Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
Eupasidin-s Tab, Stillen Tab. - Acute Gastritis, Chronic Gastritis
Phase 4CompletedChong Kun Dang Pharmaceutical2302014-08-012015-08-24
A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.
Stillen Tab., Mucosta Tab. - Acute Gastritis, Chronic Gastritis
Phase 4CompletedDong-A ST Co., Ltd.2582012-10-012021-04-15
Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients
Esomeprazole - Non Erosive Reflux Disease, Chronic Gastritis
Phase 4CompletedAstraZeneca3052010-04-012012-09-28

Narrower conditions

Gastritis (2)  ·  Stomach Neoplasms (2)  ·  Dyspepsia (1)  ·  Non-Erosive Reflux Disease (1)  ·  Peptic Ulcer (1)  ·  Stomach Ulcer (1)  ·  cyclopia sequence (1)

Broader conditions

Digestive System Diseases (5)  ·  Gastrointestinal Diseases (5)  ·  Stomach Diseases (4)  ·  Digestive System Neoplasms (2)  ·  Duodenal Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Neoplasms (2)  ·  Intestinal Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Deglutition Disorders (1)  ·  Esophageal Diseases (1)  ·  Esophageal Motility Disorders (1)  ·  Gastroesophageal Reflux (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Amoxicillin (5)  ·  Berberine (5)  ·  Bismuth (5)  ·  Clarithromycin (4)  ·  Esomeprazole (4)  ·  DA 9601 (3)  ·  1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (2)  ·  Rabeprazole (2)  ·  Furazolidone (1)  ·  Minocycline (1)  ·  Tetracycline (1)

Sponsors

Xijing Hospital of Digestive Diseases (5)  ·  AstraZeneca (1)  ·  Azfar Farogh (1)  ·  Chong Kun Dang Pharmaceutical (1)  ·  Dong-A ST Co., Ltd. (1)  ·  Mather's Pharm. Co., Ltd. (1)

Countries

China (6)  ·  South Korea (2)  ·  Pakistan (1)

Top investigators

Dae Hwan Kang, M.D., Ph.D. (1)  ·  Dong Il Park, M.D., Ph.D. (1)  ·  Hyun Yong Jeong, M.D., Ph.D. (1)  ·  In Kyung Sung, M.D.,Ph.D. (1)  ·  Jin Heung Kim, M.D., Ph.D. (1)  ·  Jin Il Kim, M.D., Ph.D. (1)  ·  Jung Il Suh, M.D., Ph.D. (1)  ·  Kwang Ro Joo, M.D., Ph.D. (1)  ·  Kyu Chan Huh, M.D., Ph.D. (1)  ·  Prof. Dr. Azfar Farogh (1)  ·  Prof. Yuan Yaozong (1)  ·  Sangyong Seol, Professor (1)  ·  Su Jin Hong, M.D., Ph.D. (1)  ·  Tae Joo Jeon, M.D., Ph.D. (1)  ·  Tea Oh Kim, M.D., Ph.D. (1)

Results publications

PMID 32348007, PMID 39180014